Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : ICN Pharmaceuticals -- Ignore unavailable to you. Want to Upgrade?

To: SeachRE who wrote (831)	4/29/1998 11:42:00 AM
From: IRWIN JAMES FRANKEL	Read Replies (1) \| Respond to of 1029

ICN has set a conference call for Thursday 4/30. My guess is they are releasing earnings early, which hopefully should not hurt us since they preannounced the currency problem that will affect the quarter. More later.

To: SeachRE who wrote (831)	4/30/1998 8:58:00 AM
From: Robert Florin	Respond to of 1029

I think that the politics and the performance of management needs to be separated. The management of this company has done a terrific job positioning the company and growing it. It has very prudently and aggressively selected markets to enter and products to sell in which ICN will be a dominant voice. Their Eastern Europe, Russia, and SOuth AMerican strategies, and the emergence of their own products promise to make ICN a first tier pharm company in the not too distant future. Comparing valuations between pharm cos results in a compelling story for ICN stock purchase.